HASHIMOTO KOICHI

Dr. HASHIMOTO KOICHI

Fukushima Regional Center for the Japan Environmental and Children's Study, Fukushima, Japan
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in Virology
Verified
Journal Article
Closed access
HKHASHIMOTO KOICHI
HASHIMOTO KOICHI
KIKei Ishibashi
Kei Ishibashi
KIKen Ishioka
Ken Ishioka
DZDongchi Zhao
Dongchi Zhao
MSMasatoki Sato
Masatoki Sato
TSTatsuo Suzutani
Tatsuo Suzutani

1 January 2017 in FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
Verified
Journal Article
Open access
PDF file
HKHASHIMOTO KOICHI
HASHIMOTO KOICHI
MHMitsuaki Hosoya
Mitsuaki Hosoya
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

21 April 2008 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
MSMakoto Sumikoshi
Makoto Sumikoshi
HKHASHIMOTO KOICHI
HASHIMOTO KOICHI
YKYukihiko Kawasaki
Yukihiko Kawasaki
HSHiroko Sakuma
Hiroko Sakuma
TSTatsuo Suzutani
Tatsuo Suzutani
MHMitsuaki Hosoya
Mitsuaki Hosoya

15 January 2021 in Molecules
Verified
Journal Article
Open access
PDF file
HKHASHIMOTO KOICHI
HASHIMOTO KOICHI
MHMitsuaki Hosoya
Mitsuaki Hosoya
Subacute sclerosing panencephalitis (SSPE) is a late-onset, intractable, and fatal viral disease caused by persistent infection of the central nervous system by a mutant strain of the measles virus. Ribavirin intracerebroventricular therapy has already been administered to several SSPE patients in Japan based on fundamental and clinical research findings from our group, with positive therapeutic effects reported in some patients. However, the efficacy of this treatment approach has not been unequivocally established. Hence, development of more effective therapeutic methods using new antiviral agents is urgently needed. This review describes the current status of SSPE treatment and research, highlighting promising approaches to the development of more effective therapeutic methods.

29 April 2022 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
YKYohei Kume
Yohei Kume
HKHASHIMOTO KOICHI
HASHIMOTO KOICHI
MCMina Chishiki
Mina Chishiki
SNSakurako Norito
Sakurako Norito
RSReiko Suwa
Reiko Suwa
MHMitsuaki Hosoya
Mitsuaki Hosoya
The impact of strengthening preventive measures against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection on the prevalence of respiratory viruses in children was examined. After the SARS‐CoV‐2 pandemic, the rate of multiple virus detection among hospitalized children decreased. Immediately after the SARS‐CoV‐2 pandemic, respiratory syncytial and parainfluenza viruses were rarely detected and subsequently reemerged. Human metapneumovirus and influenza virus were not consistently detected. Non‐enveloped viruses (bocavirus, rhinovirus, and adenovirus) were detected to some extent even after the pandemic. Epidemic‐suppressed infectious diseases may reemerge as susceptibility accumulates in the population and should continue to be monitored.

25 October 2009 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
YKYukihiko Kawasaki
Yukihiko Kawasaki
YAYoshimichi Aoyagi
Yoshimichi Aoyagi
YAYusaku Abe
Yusaku Abe
HGHayato Go
Hayato Go
TITakashi Imamura
Takashi Imamura
MHMitsuaki Hosoya
Mitsuaki Hosoya